A study, published Monday, found that when generic versions of Gilead's Truvada become available, payers should only be willing to pay a few hundred dollars more per year for Descovy, approved for PrEP in October, despite the latter's better toxicity profile.
The Ready, Set, PrEP program is designed to provide Gilead Sciences' Truvada and Descovy to up to 200,000 people who do not have prescription drug insurance coverage. Gilead is donating supplies of both drugs.
Hear executives from Quantum Health, Surescripts, EY, Clinical Architecture and Personify Health share their views on digital transformation in healthcare.
Science magazine reported that the move put the brakes on a preclinical HIV study and follows the cancellation of a contract between the FDA and a California-based company that supplies fetal tissue for medical research.
After former CDC director Brenda Fitzgerald resigned earlier this year, Dr. Robert Redfield was chosen for the position on March 21. But his appointment is marred by reports about his controversial research background.
Dr. Robert Redfield, Trump's likely pick to lead the CDC, is facing significant criticism because of a 20-year-old controversy over shoddy HIV research.
Martin Shkreli attracted a legion of negative attention from the masses thanks to his drug price hikes - and less-than-winsome persona. But can we learn something from this?
The progress in artificial intelligence (AI) is reshaping patient care, across various dimensions, from facilitating faster discharge to curating treatment plans and suggesting lifestyle changes.
The startup's gene therapy for HIV and AIDS spins out of the work from Nobel Laureate David Baltimore at CalTech. It's using the funding to further Phase I/II clinical trials.
Back when the AIDS crisis was first becoming a major public issue, gay and bisexual men who had had sex with another man since 1977 were prohibited from donating blood. Now, 32 years later, they still can’t donate, despite the fact that modern HIV screening processes are so advanced. The Food and Drug Administration’s 17-member Blood […]
Today is World AIDS Day, and many people are focused on awareness and support. Unfortunately, a story about a 22-year-old Brazilian woman is shaking up our idea of how the virus can be contracted and spread. She was recently diagnosed with HIV, and it looks like she was infected by sharing unsterilized manicure equipment with […]
Michael Weinstein, the president of the Los Angeles-based AIDS Healthcare Foundation is not necessarily who you’d expect to be standing up against Truvada – the medication created to prevent H.I.V. Truvada is used as pre-exposure prophylaxis, or PrEP. Weinsteing has called it “a public health disaster in the making.” Starting this week, the AIDS Healthcare Foundation […]
The future looks bright for the integrated specialty pharmacy model – for health systems, providers, and most importantly, for patients.
Yesterday, the Illinois Lottery Commission and the state’s Department of Public Health announced the rebirth of “Red Ribbon Cash,” an instant game lottery, which will raise an estimated $1 million for local HIV prevention services. This story illustrates one of the many strategies to offset the states’ shrinking budgets for fiscal year 2013. HIV prevention […]